A health ministry panel of experts on July 31 endorsed the plan for Daiichi Sankyo Co. to begin producing and distributing the vaccine, which creates immunity for the conventional strain of the virus.

Ippodo Gallery is now hosting Masaaki Miyasako: Living Dreams the legendary painter’s premier solo exhibition in the United States.

As one of the leading Japanese pharmaceutical companies with headquarters in Europe, Daiichi Sankyo aims to revolutionize treatment standards. Daiichi Sankyo, a pharmaceutical group boasting over ...

Japan's Foreign Ministry says additional monitoring has been carried out on treated and diluted water discharged into the ocean from the damaged Fukushima Daiichi nuclear plant. The extra tests ...

Back in 2011, the world held its breath after the Fukushima Daiichi nuclear plant in Japan suffered a failure of its cooling systems, in the wake of the country getting hit by a 9.0 magnitude ...

The campaign is presented by Daiichi-Sankyo and AstraZeneca, while Merck serves as a gold-level sponsor and Eli Lilly, Pfizer and Guardant come aboard as community sponsors. In the campaign’s ...

The International Atomic Energy Agency (IAEA) initiated today the first practical steps of additional measures at sea near the Fukushima Daiichi Nuclear Power Station (FDNPS). The IAEA carried out ...

India has 29 states with at least 720 districts comprising of approximately 6 lakh villages, and over 8200 cities and towns. Indian postal department has allotted a unique postal code of pin code ...

“..Yamada, who began his career as an artist amidst the chaos of postwar Japan, produced an extensive oeuvre comprising approximately 5,000 works over the course of ...

Daiichi Sankyo Co. will seek to maintain its edge over competitors in precision cancer therapies, by pushing ahead with clinical trials of drug candidates being developed using new technology ...

Hiroyuki Okuzawa, President and COO at Daiichi Sankyo, says the company is working to boost production of its newer-generation cancer therapies that target diseased cells, across Japan ...